The protein DNase1 is one of the oldest biological agents in history: It has been on the market since 1958 and is now used, ...

Researchers have engineered a compact, high-specificity IscB variant, NovaIscB, for safe, persistent in vivo epigenome ...

Breakthrough Nanotech Formula Combats Inflammation, Strengthens Nails, and Revitalizes Skin with Scientifically Proven ...

In a leap forward for genetic and biomedical research, two scientists at the University of Missouri have developed a powerful ...

Early research shows that editing expanding trinucleotide repeats halts the lengthening process that causes neurological ...

Blood vessels are like big-city highways; full of curves, branches, merges, and congestion. Yet for years, lab models ...

Gene delivery systems can target specific brain cells, a breakthrough that could lead to treatments for Parkinson's, ...

California Healthline: Silence On E. Coli Outbreak Highlights How Trump Team’s Changes Undermine Food Safety Food ...

Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.

UAE-based fintech startup Gainz has bagged an undisclosed seven-figure pre-seed round, structured as a mix of equity and debt ...

Over the course of my career, I’ve had three distinct moments in which I saw a brand-new app and immediately felt it was going to change how I used my computer – and they were all about empowering ...